- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Moderate to Severe Plaque-type Psoriasis in Korea, Republic of
Total 39 results
-
Bristol-Myers SquibbNot yet recruitingModerate-to-severe Plaque PsoriasisKorea, Republic of
-
Kyowa Kirin Korea Co., Ltd.CompletedModerate to Severe Plaque PsoriasisKorea, Republic of
-
GC Cell CorporationRecruitingClinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With PsoriasisModerate to Severe Plaque PsoriasisKorea, Republic of
-
UCB Biopharma SRLCompletedModerate to Severe Plaque PsoriasisKorea, Republic of
-
PfizerCompletedModerate to Severe PsoriasisKorea, Republic of
-
Samsung Bioepis Co., Ltd.CompletedPsoriasis | Moderate to Severe Plaque PsoriasisCzechia, Estonia, Hungary, Korea, Republic of, Latvia, Lithuania, Poland, Ukraine
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
EuBiologics Co.,LtdCompletedModerate to Severe Glabellar LinesKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.CompletedModerate to Severe Glabellar LineKorea, Republic of
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, United Kingdom
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisCzech Republic, Estonia, Hungary, Israel, Romania, Slovakia, Slovenia, Ukraine
-
PfizerRecruitingActive Psoriatic Arthritis | Active Ankylosing Spondylitis | Active Moderate to Severe Rheumatoid ArthritisKorea, Republic of
-
Yonsei UniversityRecruitingModerate to Severe Dry EyeKorea, Republic of
-
Novartis PharmaceuticalsCompletedModerate to Severe Nail PsoriasisGermany, Belgium, Spain, United States, Australia, United Kingdom, Denmark, Czechia, Greece
-
Hyundai Pharmaceutical Co., LTD.RecruitingModerate-to-severe Alzheimer's DiseaseKorea, Republic of
-
Novartis PharmaceuticalsCompletedModerate to Severe Palmoplantar PsoriasisBelgium, United States, Hungary, Russian Federation, Turkey, Australia, Israel, Netherlands, Portugal, Spain, United Kingdom, Norway, Slovakia, Canada, Finland
-
Asan Medical CenterSuspendedCoronavirus Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Mild to Moderate COVID-19Korea, Republic of
-
Novartis PharmaceuticalsCompletedPatients With Moderate-to-severe COPD With Destroyed Lung by TuberculosisKorea, Republic of
-
Merz North America, Inc.CompletedCorrection of Moderate to Severe Nasolabial FoldsUnited States
-
LG Life SciencesCompletedType 2 DM Patients With Moderate or Severe Renal ImpairmentKorea, Republic of
-
CinnagenCompletedAllergic Asthma | Uncontrolled Moderate to SevereIran, Islamic Republic of
-
Regeneron PharmaceuticalsSanofiCompletedModerate to Severe Atopic Hand and Foot DermatitisUnited States, Germany, Japan, Poland
-
Novartis PharmaceuticalsCompletedChronic Plaque Type PsoriasisGermany, United States, Belgium, Korea, Republic of, Spain, Taiwan, Australia, Austria, Italy, Estonia, Israel, Bulgaria, Netherlands, France, Switzerland, Portugal, Slovakia, Norway, United Kingdom, Hungary, Turkey, Canada, Denmark, ...
-
Novartis PharmaceuticalsCompletedPlaque-type PsoriasisUnited States, Austria, Germany, France, Japan, Canada, Slovakia, India
-
Merz North America, Inc.Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)United States
-
Incyte CorporationRecruitingModerate to Severe AsthmaKorea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
-
Actavis Inc.Watson Laboratories, Inc.CompletedBACTERIAL VAGINOSIS | Signs and Symptoms to be Evaluated and Recorded Include | Vaginal Discharge Color, Odor, and Consistency | Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe | Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or SevereUnited States, Dominican Republic, Puerto Rico
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate to Severe Persistent AsthmaUnited States, China, Hungary, Korea, Republic of, Poland
-
Cytos Biotechnology AGTerminatedModerate to Severe Allergic AsthmaUnited States, Czech Republic, Germany, Hungary, Israel, Poland, Russian Federation, Ukraine
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisUnited States, Australia, China, New Zealand
-
Nuon Therapeutics, Inc.CompletedHyperuricemia | Moderate to Severe GoutUnited States
-
Regeneron PharmaceuticalsSanofiCompletedHypersensitivity, Immediate | Dermatitis, Atopic | Moderate-to-Severe Atopic Dermatitis | Dermatitis, Dermatitis Atopic | Eczema, Skin Diseases, Skin | Diseases Genetic, Genetic | Diseases Inborn, Skin | Disease, Eczematous Skin | Hypersensitivity, Immune System DiseasesUnited States, Canada